| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1161/ATVBAHA.108.165530 |
| P8608 | Fatcat ID | release_7pzzwoxnrjan7m7vw4idcxovze |
| P932 | PMC publication ID | 2733228 |
| P698 | PubMed publication ID | 19359659 |
| P50 | author | Peter Libby | Q22670611 |
| Ralph Weissleder | Q7288259 | ||
| P2093 | author name string | Farouc A Jaffer | |
| P2860 | cites work | Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models | Q24657493 |
| In vivo imaging of tumors with protease-activated near-infrared fluorescent probes | Q28141852 | ||
| Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles | Q30987755 | ||
| Impact of field strength and iron oxide nanoparticle concentration on the linearity and diagnostic accuracy of off-resonance imaging | Q31132362 | ||
| Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo | Q46881126 | ||
| A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. | Q48114221 | ||
| Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. | Q51306514 | ||
| Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. | Q51935001 | ||
| Molecular imaging of cardiovascular disease. | Q53466788 | ||
| Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. | Q53541975 | ||
| Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. | Q55032942 | ||
| Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis | Q56894441 | ||
| Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle | Q57187719 | ||
| Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging | Q57188260 | ||
| In vivo imaging of proteolytic activity in atherosclerosis | Q57188411 | ||
| Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin | Q57912122 | ||
| Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor | Q58816186 | ||
| Angiographic evolution of coronary artery morphology in unstable angina | Q70018285 | ||
| Fluorescence molecular tomography resolves protease activity in vivo | Q74391149 | ||
| Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo | Q79792625 | ||
| Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis | Q79851922 | ||
| Correlation of carotid atheromatous plaque inflammation using USPIO-enhanced MR imaging with degree of luminal stenosis | Q81200106 | ||
| Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle | Q31141702 | ||
| Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging | Q31167048 | ||
| Detection of macrophage activity in atherosclerosis in vivo using multichannel, high-resolution laser scanning fluorescence microscopy. | Q33242239 | ||
| Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice | Q33243608 | ||
| Intravascular detection of inflamed atherosclerotic plaques using a fluorescent photosensitizer targeted to the scavenger receptor. | Q33619336 | ||
| In vivo molecular target assessment of matrix metalloproteinase inhibition | Q33949202 | ||
| Noninvasive detection of clinically occult lymph-node metastases in prostate cancer | Q34207093 | ||
| Simultaneous PET-MRI: a new approach for functional and morphological imaging | Q34765886 | ||
| Shedding light onto live molecular targets | Q35039563 | ||
| From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. | Q35552554 | ||
| Looking and listening to light: the evolution of whole-body photonic imaging | Q36070062 | ||
| Molecular optical imaging: applications leading to the development of present day therapeutics | Q36129726 | ||
| Atherosclerosis and proteinase activation | Q36352662 | ||
| The immune response in atherosclerosis: a double-edged sword | Q36508676 | ||
| Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization | Q36915918 | ||
| Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model | Q37039058 | ||
| Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis | Q37085672 | ||
| Imaging of atherosclerotic cardiovascular disease | Q37089743 | ||
| Multifunctional magnetic nanoparticles for targeted imaging and therapy | Q37174947 | ||
| Advances in fluorescence imaging of the cardiovascular system. | Q37177639 | ||
| Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis | Q37311936 | ||
| Nanotechnology in medical imaging: probe design and applications. | Q37341362 | ||
| Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate | Q37484967 | ||
| Imaging inflammation of the pancreatic islets in type 1 diabetes | Q37494120 | ||
| A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides | Q38501188 | ||
| Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alphavbeta3 integrin-targeted fluorochrome | Q39928440 | ||
| Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases | Q39994028 | ||
| In vivo imaging of siRNA delivery and silencing in tumors | Q40166593 | ||
| A macrophage-targeted theranostic nanoparticle for biomedical applications. | Q40189479 | ||
| Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials | Q40291013 | ||
| A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages | Q42679591 | ||
| Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging | Q42680049 | ||
| Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. | Q43153036 | ||
| Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles | Q44616397 | ||
| In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. | Q44913030 | ||
| Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. | Q46006433 | ||
| Monitoring therapeutical intervention with ezetimibe using targeted near-infrared fluorescence imaging in experimental atherosclerosis | Q46427391 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 1017-1024 | |
| P577 | publication date | 2009-04-09 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Optical and multimodality molecular imaging: insights into atherosclerosis | |
| P478 | volume | 29 |
| Q55339713 | A Dual-Modality Hybrid Imaging System Harnesses Radioluminescence and Sound to Reveal Molecular Pathology of Atherosclerotic Plaques. |
| Q39744489 | A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. |
| Q33590975 | Assessment of global cardiac uptake of radiolabeled iron oxide nanoparticles in apolipoprotein-E-deficient mice: implications for imaging cardiovascular inflammation |
| Q35690558 | Biochemical characterization of atherosclerotic plaques by endogenous multispectral fluorescence lifetime imaging microscopy |
| Q37228234 | Biological imaging of atherosclerosis: moving beyond anatomy |
| Q37762507 | Biomarkers of vulnerable atheromatous plaques: translational medicine perspectives. |
| Q49788067 | Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery |
| Q37053665 | Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation. |
| Q33693074 | Cardiovascular molecular imaging |
| Q45064544 | Cellular Uptake of Plain and SPION-Modified Microbubbles for Potential Use in Molecular Imaging |
| Q28538538 | Comprehensive evaluation of the anti-angiogenic and anti-neoplastic effects of Endostar on liver cancer through optical molecular imaging |
| Q57810163 | Computational Cardiology |
| Q41459121 | Convenient and effective ICGylation of magnetic nanoparticles for biomedical applications. |
| Q38848673 | Detection and treatment of atherosclerosis using nanoparticles |
| Q36396054 | Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles |
| Q30525312 | Detection of hydroxyapatite in calcified cardiovascular tissues |
| Q42736765 | Detection of macrophages via paramagnetic vesicles incorporating oxidatively tailored cholesterol ester: an approach for atherosclerosis imaging. |
| Q50516003 | Development and haematotoxicological evaluation of doped hydroxyapatite based multimodal nanocontrast agent for near-infrared, magnetic resonance and X-ray contrast imaging. |
| Q36095999 | Discrete bimodal probes for thrombus imaging |
| Q41573147 | Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma. |
| Q46232358 | Efficient synthesis of fluorescent-PET probes based on [¹⁸F]BODIPY dye. |
| Q30475719 | Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases |
| Q35086168 | FRET-based and other fluorescent proteinase probes. |
| Q35262149 | Fiber-optic system for dual-modality imaging of glucose probes 18F-FDG and 6-NBDG in atherosclerotic plaques |
| Q37425779 | Fluorescent Bisphosphonate and Carboxyphosphonate Probes: A Versatile Imaging Toolkit for Applications in Bone Biology and Biomedicine |
| Q36731084 | Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles |
| Q42690584 | Glycolaldehyde and maleyl conjugated human serum albumin as potential macrophage-targeting carriers for molecular imaging purposes |
| Q36572425 | High-resolution molecular imaging via intravital microscopy: illuminating vascular biology in vivo |
| Q39763138 | Hybrid FMT-MRI applied to in vivo atherosclerosis imaging |
| Q57907277 | Imaging and quantifying the morphology of an organic–inorganic nanoparticle at the sub-nanometre level |
| Q38844535 | Imaging of coronary atherosclerosis - evolution towards new treatment strategies |
| Q30448146 | Improving quantification of intravascular fluorescence imaging using structural information |
| Q34288844 | In vivo fluorescence reflectance imaging of protease activity in a mouse model of post-traumatic osteoarthritis |
| Q37791278 | In vivo imaging in cancer |
| Q33994368 | In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis |
| Q30472773 | Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques |
| Q42134447 | Inflammation modulates murine venous thrombosis resolution in vivo: assessment by multimodal fluorescence molecular imaging |
| Q34230328 | Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo |
| Q64986208 | Intravascular NIRF Molecular Imaging Approaches in Coronary Artery Disease. |
| Q39874491 | Intravascular near-infrared fluorescence molecular imaging of atherosclerosis |
| Q27334277 | Intravascular optical imaging of high-risk plaques in vivo by targeting macrophage mannose receptors |
| Q26852822 | Intravascular optical imaging technology for investigating the coronary artery |
| Q36761866 | Long-term prevalence of NIRF-labeled magnetic nanoparticles for the diagnostic and intraoperative imaging of inflammation. |
| Q36088710 | MRI as a Novel In Vivo Approach for Assessing Structural Changes of Chlamydia Pathology in a Mouse Model. |
| Q38820074 | Macrophages in Vascular Inflammation: Origins and Functions |
| Q30475508 | Mass spectrometric imaging for biomedical tissue analysis |
| Q92378330 | Molecular Imaging of the Heart |
| Q30474772 | Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification |
| Q41819473 | Molecular imaging of atherosclerosis: clinical state-of-the-art |
| Q36036217 | Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence |
| Q58816167 | Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo |
| Q30467394 | Multispectral optoacoustic tomography of matrix metalloproteinase activity in vulnerable human carotid plaques |
| Q38828033 | Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis |
| Q37724631 | Nanomedicine and Cardiovascular Disease |
| Q33902889 | Near-infrared autofluorescence induced by intraplaque hemorrhage and heme degradation as marker for high-risk atherosclerotic plaques. |
| Q39068959 | Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome |
| Q87816699 | Non-destructive two-photon excited fluorescence imaging identifies early nodules in calcific aortic-valve disease |
| Q37663867 | Optical molecular imaging in atherosclerosis |
| Q37859341 | Optical molecular imaging of atherosclerosis using nanoparticles: shedding new light on the darkness |
| Q37772807 | Optical techniques for the molecular imaging of angiogenesis |
| Q37058474 | Optical tecnology developments in biomedicine: history, current and future |
| Q34736942 | Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery. |
| Q30455490 | Perspectives and opportunities for nanomedicine in the management of atherosclerosis. |
| Q34537454 | Pioglitazone suppresses inflammation in vivo in murine carotid atherosclerosis: novel detection by dual-target fluorescence molecular imaging. |
| Q36792762 | Positron Emission Tomography and Magnetic Resonance Imaging of Cellular Inflammation in Patients with Abdominal Aortic Aneurysms |
| Q36339573 | Quantitative In Vivo Detection of Chlamydia muridarum Associated Inflammation in a Mouse Model Using Optical Imaging |
| Q36355372 | Quantitative Longitudinal Imaging of Vascular Inflammation and Treatment by Ezetimibe in apoE Mice by FMT Using New Optical Imaging Biomarkers of Cathepsin Activity and α(v)β(3) Integrin |
| Q35058188 | Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging |
| Q35433466 | Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis |
| Q90022992 | Small-animal 360-deg fluorescence diffuse optical tomography using structural prior information from ultrasound imaging |
| Q26776370 | Smart nanosystems: Bio-inspired technologies that interact with the host environment |
| Q51446926 | Strong correlation between early stage atherosclerosis and electromechanical coupling of aorta. |
| Q39782073 | The catheterization laboratory and interventional vascular suite of the future: anticipating innovations in design and function |
| Q38962280 | Tumor vascular homing endgolin-targeted radioimmunotherapy in hepatocellular carcinoma |
| Q38989758 | Ultrasound guided fluorescence molecular tomography with improved quantification by an attenuation compensated Born-normalization and in vivo preclinical study of cancer |
| Q37729836 | Will molecular optical imaging have clinically important roles in stroke management, and how? |
Search more.